Latour, Sylvain
l'Institut des Maladies Génétiques Imagine,
France
2025 Rank: 107861
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Allergy
Rank in SubField 1: 2864 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 107861 | 107844 |
| Total Cites | 9279 | 10977 |
| H-index | 50 | 55 |
| Hm-index | 15 | 15 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 34 | 39 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 1470 | 1693 |
| Number of Single+First+Last Authored Papers | 50 | 50 |
| Total Cites to Single+First+Last Authored Papers | 3911 | 4474 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6859 | 7650 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.43 |
| Self-Citation Percentage |
15.47%
|
|
Latour, Sylvain
Inserm,
France
2024 Rank: 106984
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Allergy
Rank in SubField 1: 2895 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 106984 | 107291 |
| Total Cites | 8619 | 10164 |
| H-index | 49 | 54 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 32 | 37 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 1405 | 1626 |
| Number of Single+First+Last Authored Papers | 46 | 46 |
| Total Cites to Single+First+Last Authored Papers | 3654 | 4182 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6384 | 7090 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.43 |
| Self-Citation Percentage |
15.20%
|
|
Latour, Sylvain
Université Paris Cité,
France
2023 Rank: 106087
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Allergy
Rank in SubField 1: 2905 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 106087 | 108348 |
| Total Cites | 8005 | 9437 |
| H-index | 48 | 51 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 30 | 34 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 1330 | 1548 |
| Number of Single+First+Last Authored Papers | 44 | 44 |
| Total Cites to Single+First+Last Authored Papers | 3406 | 3914 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5930 | 6573 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.44 |
| Self-Citation Percentage |
15.17%
|
|
Latour, Sylvain
l'Institut des Maladies Génétiques Imagine,
France
2021 Rank: 98035
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Developmental Biology
Rank in SubField 1: 2753 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 98035 | 98971 |
| Total Cites | 7282 | 8539 |
| H-index | 45 | 50 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 27 | 31 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 1230 | 1441 |
| Number of Single+First+Last Authored Papers | 38 | 38 |
| Total Cites to Single+First+Last Authored Papers | 2984 | 3440 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5488 | 6049 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.41 |
| Self-Citation Percentage |
14.72%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.